1. Developments in RNA splicing and disease
- Author
-
Michael G. Poulos, Konstantinos Charizanis, Ranjan Batra, and Maurice S. Swanson
- Subjects
Genetics ,RNA Splicing ,Alternative splicing ,Intron ,Exonic splicing enhancer ,RNA-binding protein ,Computational biology ,Neuromuscular Diseases ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Post-transcriptional modification ,Splicing factor ,RNA editing ,RNA splicing ,Spliceosomes ,Humans ,RNA, Messenger ,Microsatellite Repeats ,Perspectives - Abstract
Pre-mRNA processing, including 5'-end capping, splicing, editing, and polyadenylation, consists of a series of orchestrated and primarily cotranscriptional steps that ensure both the high fidelity and extreme diversity characteristic of eukaryotic gene expression. Alternative splicing and editing allow relatively small genomes to encode vast proteomic arrays while alternative 3'-end formation enables variations in mRNA localization, translation, and stability. Of course, this mechanistic complexity comes at a high price. Mutations in the myriad of RNA sequence elements that regulate mRNA biogenesis, as well as the trans-acting factors that act upon these sequences, underlie a number of human diseases. In this review, we focus on one of these key RNA processing steps, splicing, to highlight recent studies that describe both conventional and novel pathogenic mechanisms that underlie muscle and neurological diseases.
- Published
- 2010